Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00578383 · ClinicalTrials.gov registry record · NA

Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device

A NA study of Depression and Major Depressive Disorder, sponsored by Mclean Hospital.

Completed
Registry status
NA
Development phase
107
Enrollment target
1
Study location

NCT00578383 is a NA study of Depression and Major Depressive Disorder that has completed, run by Mclean Hospital. The registered enrollment target is 107 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00578383, a NA study of Depression and Major Depressive Disorder, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
1
Study location

Study Summary

This study is designed to test whether low-field magnetic stimulation (LFMS) can relieve some of the symptoms of depression in bipolar disorder or major depression.

Interventions

  • DEVICE Low Field Magnetic Stimulation Device

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2007-11
Est. Completion 2013-03
Phase NA

Sponsor

Mclean Hospital

140 total trials

What the Registry Record Tells You About NCT00578383

The ClinicalTrials.gov registry entry for NCT00578383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (86% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Low Field Magnetic Stimulation Device is the first listed.

NCT00578383 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00578383 about?

NCT00578383 is a clinical study titled "Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device". This study is designed to test whether low-field magnetic stimulation (LFMS) can relieve some of the symptoms of depression in bipolar disorder or major depression.

What is the current status of trial NCT00578383?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2007-11. Estimated completion is 2013-03.

What conditions does trial NCT00578383 study?

This clinical trial studies the following conditions: Depression, Major Depressive Disorder, Bipolar Depression.

What interventions are being tested in trial NCT00578383?

The interventions under investigation include: Low Field Magnetic Stimulation Device (DEVICE).

Who is sponsoring clinical trial NCT00578383?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00578383 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.